17Dec
Related Posts
02Jun
Next Science (ASX:NXS) BlastX antimicrobial wound gel
02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
Read More
07Dec
ResApp Health (ASX:RAP) – managing respiratory disease and sleep apnoea
07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
Read More
25Feb
Noxopharm (ASX:NOX) LuPIN trial in prostate cancer
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
Read More
01Mar
IVE Group (ASX:IGL) 1H21 results & outlook
01 Mar 2021 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig talks about the company's strong 1H21 results on the back of a rebound in activity as the adverse impact of COVID disruptions diminishes.
Read More
01Mar
Significant results for Nyrada’s brain injury treatment
01 Mar 2024 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses results for using NYR-B103 to treat brain injuries.
Read More
02Feb
Centuria Industrial REIT (ASX:CIP) 1H21 results & outlook
02 Feb 2021 - Centuria Industrial REIT (ASX:CIP) Fund Manager, Jesse Curtis talks 1H21 highlights, acquisitions, leasing activity and second half guidance.
Read More
03Mar
IVE Group (ASX:IGL) delivers 31% increase in revenue
03 Mar 2023 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the company's half-year financial results, commenting on key drivers, the Lasoo platform launch, the Ovato acquisition and the company's partnership with Iberdrola.
Read More
17Jul
Market update with Shaw and Partners, July 2023
14 July 2023 - Shaw and Partners Chief Investment Officer Martin Crabb takes a look at the current economic situation and what it means for portfolios and investments going forward.
Read More
22Jun
Andrew Schwartz, Founder of the Qualitas Group
22 Jun 2020 - An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.
Read More
07Sep
IVE Group (ASX:IGL) positioned for growth
07 Sep 2022 - IVE Group (ASX:IGL) Executive Chairman Geoff Selig discusses full-year results, the recent acquisition of Ovato and the launch of the Lasoo e-commerce platform.
Read More